Biotech

Oxolife SL

Pilar Puig, 25 October, 2019, 0

Oxolife SL Small-size clinical-stage company developing a firts in class treatment for female infertility. Biotech Development, market readiness, clinical trial...

+

Forchronic, S.L.

Pilar Puig, 7 October, 2019, 0

Forchronic, S.L. New natural nutraceutical products and food supplements with therapeutical activity in cancer and immune disorders. Biotech Development, market...

+

Biocross

martaGaspar, 17 September, 2019, 0

Biocross e4Risk: a new, non genetic method to evaluate Alzheimer's disease risk Biotech Sales, licensing phases Spain 1.000.000€ You can...

+

Ikan Biotech

John Bethell, 15 July, 2019, 0

Ikan Biotech Biotech company that develops an in vivo platform to evaluate personalized cancer treatments Biotech Development, market readiness, clinical...

+

NANOGAP Therapeutics

John Bethell, 8 May, 2019, Evaluation Complete 7+, Premium Client, 0

NANOGAP Therapeutics Using a new class of chemical to treat currently untreatable cancer Biotech Prototyping, preclinical Spain 450.000€ You can...

+

MANREMYC

James Prickett - BEN Admin, 28 March, 2019, Evaluation Complete 7+, 0

MANREMYC We develop the first natural food supplement to reduce the risk of developing active tuberculosis Biotech Sales, licensing phases...

+

InnoUp Farma

James Prickett - BEN Admin, 23 January, 2019, 0

InnoUp Farma Drug enhancement through nanotechnology. Biotech Development, market readiness, clinical trial España 500.000€ You can visit their website or...

+

Bionox Group Spain S.L.

Pilar Puig, 29 October, 2018, 0

Bionox Group Spain S.L. Biotechnology company that develops and markets biofunctional and smart textiles Biotech Development, market readiness, clinical trial...

+

Ariddad Therapeutics SL

Pilar Puig, 23 October, 2018, 0

Ariddad Therapeutics The first-in-its-class medicinal drug with double action Biotech In vivo, proof of concept Spain 500.000€ You can...

+

Glycoscience

Pilar Puig, 10 October, 2018, 0

Glycoscience Development of a new line of insect repellents with improved efficacy and safety Biotech In vitro, proof of concept...